Opportunity Information: Apply for CDC RFA GH19 1933

This funding opportunity, issued by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), supports a PEPFAR-backed effort to speed up and strengthen comprehensive HIV prevention, care, and treatment services in the Democratic Republic of Congo, with a specific focus on selected Health Zones in Haut-Katanga province. The overall intent is to push the local HIV response toward epidemic control by expanding access to high-impact, evidence-based services and by improving how quickly people move through the full HIV service delivery cascade, from testing and diagnosis to treatment initiation and long-term retention in care. The program is designed to be implemented in close coordination with the Government of the DRC, particularly the Ministry of Health, so that improvements are not only rapid but also sustainable and embedded within provincial and Health Zone systems.

A major emphasis of the program is identifying people living with HIV who do not yet know their status, using targeted approaches rather than relying only on broad, untargeted testing. The opportunity highlights index testing and contact elicitation as a key strategy, meaning that when someone tests positive, eligible contacts (such as sexual partners or others at risk, as appropriate and safe) are proactively offered testing services. This approach is intended to increase case-finding efficiency and reach individuals who are more likely to be HIV-positive but may not otherwise present for testing. Alongside testing, the funded work is expected to strengthen linkage to care so that newly diagnosed individuals are promptly connected to treatment services, reducing loss between diagnosis and enrollment in HIV care.

The NOFO also calls for a comprehensive package that goes beyond testing and antiretroviral therapy. It explicitly includes community outreach and support services delivered through Orphans and Vulnerable Children (OVC) platforms, recognizing that household vulnerability, poverty, and social instability can directly affect HIV risk and a person’s ability to stay engaged in care. By integrating OVC-related outreach with HIV services, the program aims to improve prevention, facilitate earlier testing, and support adherence and retention for affected children, adolescents, and caregivers. In addition, prevention services are meant to be implemented in a way that is responsive to local patterns of transmission and barriers to service access.

Integration with tuberculosis (TB) services is another core component. The opportunity includes TB/HIV prevention, diagnosis, and treatment services, reflecting the high burden and clinical importance of TB as a leading cause of illness and death among people living with HIV. In practice, this means strengthening screening for TB among people with HIV, ensuring timely diagnosis, and linking patients to appropriate TB treatment while also providing HIV-related prevention and treatment. The goal is to reduce missed TB cases, improve clinical outcomes, and deliver more coordinated, patient-centered care.

Prevention of Mother-to-Child Transmission (PMTCT) is also prioritized, with attention to both the general population and key populations (KP). The PMTCT focus signals an expectation that maternal HIV testing and treatment, infant testing, and follow-up services will be strengthened so that pregnant and breastfeeding women living with HIV are identified early, started or maintained on effective therapy, and supported through the perinatal period to prevent infant infections. Mentioning key populations alongside PMTCT suggests the program should be prepared to address gaps in access and stigma-related barriers that may affect pregnant women from marginalized groups, and to ensure services are respectful, confidential, and accessible.

To make the clinical and outreach components effective at scale, the NOFO includes associated laboratory and strategic information (SI) services. Laboratory support typically involves ensuring that essential diagnostics and monitoring tools are available and functioning, and that results are used in clinical decision-making in a timely manner. Strategic information refers to the systems and practices used to collect, validate, analyze, and use data to guide program decisions. The notice places strong weight on improving data quality and data use, implying that the recipient is expected to strengthen routine reporting, improve the accuracy and completeness of program data, and help teams use information for real-time problem solving, such as identifying drop-offs in linkage or retention and responding quickly.

A defining feature of the opportunity is its explicit stigma-free approach. This reflects an understanding that fear of discrimination, breaches of confidentiality, and negative treatment in health facilities or communities can keep people from seeking testing, disclosing risk, initiating treatment, or staying in care. The recipient is expected to implement services in ways that reduce stigma and make care more welcoming and safe, which is especially important for key populations and for anyone who may be socially vulnerable. This stigma-free orientation is closely tied to the program’s reliance on community engagement and the role of capable community organizations in improving uptake of services, strengthening linkage, and supporting retention.

The cooperative agreement mechanism indicates that this award is not intended to be a hands-off grant; instead, CDC is expected to be substantially involved in supporting, guiding, and collaborating on implementation. The recipient will provide both direct support and technical assistance to accelerate service delivery in the selected Health Zones and to build local capacity. A key expectation is close work with the Ministry of Health to strengthen provincial and Health Zone team capabilities, which often includes coaching, mentorship, planning support, and improvements in management practices and service quality. The idea is to improve performance now while also leaving behind stronger local systems that can maintain progress over time.

From an administrative standpoint, this is a discretionary funding opportunity with a single expected award. The funding instrument type is a cooperative agreement, the activity category is health, and it falls under CFDA 93.067. Eligible applicants are listed as unrestricted, meaning the opportunity is broadly open to different types of entities, as long as they meet any additional eligibility conditions described in the full announcement. The opportunity number is CDC RFA GH19 1933, with an award ceiling of $3,500,000 and one anticipated recipient. The NOFO was created on August 21, 2018, with an original application closing date of October 22, 2018, and electronic submissions due by 11:59 p.m. Eastern Time on the deadline.

Taken together, the opportunity is structured around a clear public health endpoint: moving Haut-Katanga’s targeted Health Zones toward HIV epidemic control and contributing to the broader ambition of eliminating HIV as a public health threat by 2030. It does this by combining targeted case-finding, stronger linkage and retention, integrated TB/HIV services, robust PMTCT programming for both general and key populations, community-based support through OVC and other community partners, and a strong focus on laboratory capacity and data-driven management. The underlying logic is that epidemic control depends not just on offering services, but on making sure the right people are reached, services are delivered consistently and respectfully, and local teams have the skills and information needed to continuously improve performance.

  • The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Enhance Population Access to Comprehensive HIV/AIDS Services in order to Achieve HIV/AIDS Epidemic Control in the Democratic Republic of Congo (DRC), Specifically in Haut - Katanga under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
  • This funding opportunity was created on Aug 21, 2018.
  • Applicants must submit their applications by Oct 22, 2018 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $3,500,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for CDC RFA GH19 1933

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

1) What is this funding opportunity about?

This CDC funding opportunity supports a PEPFAR-backed effort to accelerate and strengthen comprehensive HIV prevention, care, and treatment services in the Democratic Republic of Congo (DRC), with a specific focus on selected Health Zones in Haut-Katanga province. The work is intended to move the local HIV response toward epidemic control by expanding access to high-impact, evidence-based services and improving performance across the full HIV service delivery cascade.

2) Who is issuing the award?

The opportunity is issued by the U.S. Department of Health and Human Services (HHS) through the Centers for Disease Control and Prevention (CDC).

3) What is the main public health goal of the program?

The main goal is to push targeted Health Zones in Haut-Katanga toward HIV epidemic control by improving how quickly and consistently people move from HIV testing and diagnosis to treatment initiation and long-term retention in care. The opportunity also aligns with the broader ambition of eliminating HIV as a public health threat by 2030.

4) Where will the program be implemented?

The program focuses on selected Health Zones in Haut-Katanga province in the Democratic Republic of Congo. Implementation is expected to be coordinated closely with national and local structures, especially the Ministry of Health.

5) What types of HIV services are emphasized?

The NOFO emphasizes comprehensive HIV prevention, care, and treatment services, including targeted HIV case-finding, strengthened linkage to care, treatment initiation support, and long-term retention and adherence support. It also includes prevention approaches responsive to local transmission patterns and barriers to access.

6) What does the NOFO mean by improving the HIV service delivery cascade?

It means improving performance across the steps people move through in HIV services: testing and diagnosis, prompt linkage to treatment services, treatment initiation, and sustained retention in care over time. The program aims to reduce delays and losses between each step.

7) How does the opportunity expect applicants to find people living with HIV who do not know their status?

The opportunity prioritizes targeted approaches rather than relying only on broad, untargeted testing. A highlighted strategy is index testing and contact elicitation, where eligible contacts of someone who tests positive (such as sexual partners or others at risk, as appropriate and safe) are proactively offered testing services.

8) What is index testing and contact elicitation in this program context?

Index testing is a targeted case-finding approach that starts with a person newly identified as HIV-positive and then offers testing to eligible contacts who may be at risk, as appropriate and safe. The goal is to increase testing efficiency and reach people who are more likely to be HIV-positive but may not otherwise seek testing.

9) What is expected regarding linkage to HIV care after diagnosis?

The funded work is expected to strengthen linkage to care so that newly diagnosed individuals are promptly connected to treatment services. This is intended to reduce losses between diagnosis and enrollment in HIV care.

10) Does the program include support beyond clinical HIV services?

Yes. The NOFO explicitly includes community outreach and support services delivered through Orphans and Vulnerable Children (OVC) platforms, recognizing that household vulnerability, poverty, and social instability can affect HIV risk and a person’s ability to stay engaged in care.

11) How are OVC platforms expected to be used?

OVC platforms are expected to support community outreach and household-level services that help improve prevention, facilitate earlier testing, and support adherence and retention among affected children, adolescents, and caregivers.

12) How does the opportunity address HIV prevention?

Prevention services are expected to be implemented in a way that responds to local patterns of transmission and barriers to service access, and to be part of a comprehensive approach alongside testing, treatment, and community support.

13) Is integration with tuberculosis (TB) services required?

Integration with TB services is described as a core component. The opportunity includes TB/HIV prevention, diagnosis, and treatment services to address TB as a leading cause of illness and death among people living with HIV.

14) What does TB/HIV integration look like in practice under this NOFO?

It includes strengthening TB screening among people with HIV, ensuring timely TB diagnosis, linking patients to appropriate TB treatment, and coordinating TB and HIV prevention and treatment services to deliver more patient-centered care and reduce missed TB cases.

15) Is Prevention of Mother-to-Child Transmission (PMTCT) included?

Yes. PMTCT is prioritized, including strengthening maternal HIV testing and treatment, infant testing, and follow-up services to prevent infant infections.

16) Does PMTCT include attention to key populations?

Yes. The NOFO mentions PMTCT for both the general population and key populations (KP), suggesting attention to gaps in access and stigma-related barriers, and an expectation that services are respectful, confidential, and accessible for marginalized groups.

17) What laboratory services are expected under this award?

The NOFO includes associated laboratory support to help ensure essential diagnostics and monitoring tools are available and functioning, and that results are used in clinical decision-making in a timely manner.

18) What are “strategic information (SI)” services in this opportunity?

Strategic information refers to systems and practices for collecting, validating, analyzing, and using data to guide program decisions. The opportunity emphasizes improving data quality and data use, including routine reporting, data accuracy and completeness, and real-time problem solving based on program data.

19) Why does the NOFO stress data quality and data use?

The NOFO places strong weight on improving data quality and use so teams can identify and address performance gaps quickly (for example, drop-offs in linkage or retention) and continuously improve service delivery.

20) What does “stigma-free approach” mean in the context of this program?

It means services should be implemented in ways that reduce discrimination and fear, protect confidentiality, and make care welcoming and safe. The NOFO links stigma reduction to better uptake of testing, disclosure of risk where relevant, treatment initiation, and long-term retention, particularly for key populations and socially vulnerable groups.

21) How important is community engagement in this opportunity?

Community engagement is a central theme. The NOFO highlights the role of capable community organizations in improving service uptake, strengthening linkage, and supporting retention, alongside community outreach through OVC and related platforms.

22) What does it mean that the award is a “cooperative agreement”?

A cooperative agreement indicates CDC is expected to be substantially involved in supporting, guiding, and collaborating on implementation. The program is not intended to be hands-off; the recipient and CDC work closely during implementation.

23) What is expected regarding coordination with the Government of the DRC?

The program is designed to be implemented in close coordination with the Government of the DRC, particularly the Ministry of Health, to help ensure improvements are rapid, sustainable, and embedded within provincial and Health Zone systems.

24) What kinds of capacity building are anticipated?

The recipient is expected to provide direct support and technical assistance to accelerate service delivery and build local capacity, including strengthening provincial and Health Zone team capabilities through activities such as coaching, mentorship, planning support, and improvements in management practices and service quality.

25) How many awards are expected?

The NOFO indicates a single expected award, with one anticipated recipient.

26) What is the maximum award amount (ceiling)?

The award ceiling is $3,500,000.

27) What is the opportunity number?

The opportunity number is CDC RFA GH19 1933.

28) What is the CFDA number for this opportunity?

The opportunity falls under CFDA 93.067.

29) What is the funding instrument type and activity category?

The funding instrument type is a cooperative agreement, and the activity category is health.

30) Who is eligible to apply?

Eligible applicants are listed as unrestricted, meaning the opportunity is broadly open to different types of entities, as long as they meet any additional eligibility conditions described in the full announcement.

31) When was the NOFO created and what was the original application deadline?

The NOFO was created on August 21, 2018. The original application closing date was October 22, 2018, with electronic submissions due by 11:59 p.m. Eastern Time on the deadline.

32) What makes this opportunity “comprehensive” rather than focused on a single intervention?

The NOFO combines targeted HIV case-finding (including index testing), stronger linkage and retention, integrated TB/HIV services, prioritized PMTCT for general and key populations, community-based support through OVC and community partners, and laboratory plus strategic information systems. The design reflects the idea that epidemic control requires coordinated services, respectful delivery, and strong data-driven management.

Browse more opportunities from the same agency: Department of Health and Human Services, Centers for Disease Control - CGH

Browse more opportunities from the same category: Health

Next opportunity: Science Summer Camp

Previous opportunity: Historic Preservation Fund Grants to Underrepresented Communities

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA GH19 1933

 

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA GH19 1933) also looked into and applied for these:

Funding Opportunity
Rural Opioids Technical Assistance Grants Apply for TI 18 022

Funding Number: TI 18 022
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis
Category: Health
Funding Amount: $8,250,000
Packaging and Spreading Proven Pediatric Weight Management Interventions for Use by Low-Income Families Apply for RFA DP 19 002

Funding Number: RFA DP 19 002
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $750,000
Building and Improving Laboratory Capacity and Quality in the Democratic Republic of Congo (DRC) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1932

Funding Number: CDC RFA GH19 1932
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $1,500,000
Lost Wages Support for Living Organ Donors Demonstration Project Apply for HRSA 19 069

Funding Number: HRSA 19 069
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Rural Health Network Development Planning Program Apply for HRSA 19 025

Funding Number: HRSA 19 025
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Rape Prevention and Education: Using The Best Available Evidence for Sexual Violence Prevention Apply for CDC RFA CE19 1902

Funding Number: CDC RFA CE19 1902
Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC
Category: Health
Funding Amount: $3,500,000
Improving Laboratory Capacity and Quality in the Scale-up of HIV Diagnosis, Care, Treatment, and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1910

Funding Number: CDC RFA GH19 1910
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $10,000,000
Consolidating Efforts Towards HIV and TB Epidemic Control in the Kenya Prisons Service (KPS) through Scale Up of High Quality HIV and TB Services, Capacity Strengthening, and Health System Strengthening under PEPFAR Apply for CDC RFA GH19 1928

Funding Number: CDC RFA GH19 1928
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $2,500,000
Improving Quality of Care and Health Impact through Innovative Electronic Medical System Technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1912

Funding Number: CDC RFA GH19 1912
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $10,000,000
Optimizing Performance by Improving Quality (OPIQ) in HIV and HIV/TB Programs in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1921

Funding Number: CDC RFA GH19 1921
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $5,000,000
Enhance the National Department of Health's Coordination and Leadership on HIV and TB Programs in South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1913

Funding Number: CDC RFA GH19 1913
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $90,000,000
Strengthening Strategic Information, Program Implementation and Capacity Building in order to Reduce Morbidity and Mortality in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1911

Funding Number: CDC RFA GH19 1911
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $2,500,000
Strengthening the Delivery of and Expanding Access to Quality Laboratory Services and Laboratory Safety in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1919

Funding Number: CDC RFA GH19 1919
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $8,000,000
Supporting the South African National AIDS Council Trust (SANAC Trust) in the Coordination, Management, and Monitoring of the Multi-Sectoral Implementation of the National Strategic Plan (NSP) under PEPFAR Apply for CDC RFA GH19 1914

Funding Number: CDC RFA GH19 1914
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $2,500,000
Strengthening Health System Capacity for the Use of Human Resources for Health Data for Implementing HIV Prevention, Care and Treatment Programs in the Republic of South Africa under the United States President's Emergency Plan for AIDS Relief ( Apply for CDC RFA GH19 1955

Funding Number: CDC RFA GH19 1955
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $10,000,000
USAID/Malawi HIV Prevention Activities Apply for RFI 612 18 HIVPREV 01

Funding Number: RFI 612 18 HIVPREV 01
Agency: Agency for International Development, Malawi USAID-Lilongwe
Category: Health
Funding Amount: $75,000,000
Service Area Competition Apply for HRSA 19 016

Funding Number: HRSA 19 016
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Delta Health Care Service Grant Program Apply for RDBCP DHCS 2018

Funding Number: RDBCP DHCS 2018
Agency: Department of Agriculture, Business and Cooperative Programs
Category: Health
Funding Amount: $1,000,000
HIV Prevention, Care, and Treatment Support for Church-related Hospitals and Clinics in the Republic of Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1944

Funding Number: CDC RFA GH19 1944
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $1,980,401
Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center: Synergizing Career Development toward Improved Care of Older Adults across Specialties and Disciplines (U24 - Clinical Trial Optional) Apply for RFA AG 19 024

Funding Number: RFA AG 19 024
Agency: Department of Health and Human Services, National Institutes of Health
Category: Health
Funding Amount: $700,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH19 1933", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: